International Stem Cell CORP (ISCO) › Cash & EquivalentsInternational Stem Cell CORP (ISCO) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2009-12-31: $727.0K2010-12-31: $5.78M2011-12-31: $1.34M2012-12-31: $654.0K2013-12-31: $2.24M2014-12-31: $1.11M2015-12-31: $532.0K2016-12-31: $110.0K2017-12-31: $304.0K$304.0K2009-12-31Cash & Equivalents (USD)2017-12-31Period endedCash & EquivalentsChange YoYSource filing2017-12-31$304.0K+176.4%2018-04-09Balance as of period end2016-12-31$110.0K-79.3%2018-04-09Balance as of period end2015-12-31$532.0K-52.1%2018-04-09Balance as of period end2014-12-31$1.11M-50.5%2017-03-31Balance as of period end2013-12-31$2.24M+243.0%2016-03-30Balance as of period end2012-12-31$654.0K-51.1%2015-03-30Balance as of period end2011-12-31$1.34M-76.9%2014-03-17Balance as of period end2010-12-31$5.78M+695.3%2013-03-26Balance as of period end2009-12-31$727.0K—2012-03-16Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)